Antimicrobial resistance (AMR) is a major global health threat associated with extensive morbidity and mortality in humans and animals. The work at the Slizovskiy Laboratory of Infectious Diseases and Antimicrobial Resistance Research (LIDAAR) addresses this challenge by developing sequencing, computational, and statistical tools to characterize and predict risks of AMR in bacteria found within human, animal, food, and environmental microbiomes. Utilizing these results, we work on deploying microbiome-level interventions to de-escalate AMR pressure and related health sequelae.
Featured research
News
May 13 to 15, 2024:
The Slizovskiy lab is presenting at the Midwest Microbiome Symposium, “Advancements in metagenomics for microbiome-wide profiling of genes and genomes of public health importance.” West Lafayette, Indiana, USA.
April 12, 2024:
The Slizovskiy lab is showcasing technology innovation coming out from their lab, at Industry Partner Days, “Technology for direct microbiome-wide sequencing of pathogens and their genes.” West Lafayette, Indiana, USA.
March 07, 2024:
The Slizovskiy lab has secured its start up funding!
We are now *beginning a new search* for post-doctoral scholars or PhD students with a focus in bioinformatics. Please send us your letter of interest and CV to islizovs@purdue.edu!
February 12, 2024:
The Slizovskiy lab opens its doors at Purdue University. We are planning to hire a post-doctoral fellow, undergraduates, and summer scholars. Stay tuned!
